Research & development decreased 33.3%
Research & development changed -33.3% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Research & development changed -33.3% from the comparable as-filed period.
Cash & equivalents changed +102.2% from the comparable as-filed period.
Inventory changed -39.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Cash / debt changed +3256 basis points from the comparable as-filed period.
Net debt changed -47.7% from the comparable as-filed period.
Debt / assets changed +159 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Working capital changed -207.1% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
Operating income changed +102.9% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Shares outstanding changed +8.9% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
Current assets changed +8.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Gross debt changed +0.7% from the comparable as-filed period. The change ranks at the 0th percentile of 6 prior comparable changes. This reverses 6 consecutive comparable moves in the opposite direction.
Reported total debt changed +0.7% from the comparable as-filed period. The change ranks at the 0th percentile of 6 prior comparable changes. This reverses 6 consecutive comparable moves in the opposite direction.
Total assets changed -7.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Trade receivables changed +2.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.